Discuss fda and/or clinical practice guidelines


Problem: Choose one of the following diagnoses: Bipolar I, Bipolar II, Cyclothymic Disorder, Substance/Medication-Induced Bipolar and Related Disorder, Bipolar and Related Disorder Due to Another Medical Condition.

Explain:

1. Prevalence and Neurobiology of your chosen disorder

2. Discuss the differences between your chosen disorder and one other bipolar and related disorders in relation to the diagnostic criteria including presentation of symptoms according to DSM 5 TR criteria

3. Discuss special populations and considerations (children, adolescents, pregnancy/post-partum, older adult, emergency care) for your chosen bipolar and related disorder; demonstrating critical thinking beyond basics of HIPPA and informed consent with discussion of at least one for EACH category:  legal considerations, ethical considerations, cultural considerations, social determinants of health

4. Discuss FDA and/or clinical practice guidelines approved pharmacological treatment options in relation to acute and mixed episodes vs maintenance pharmacological treatment for your chosen bipolar and related disorder

5. Of the medication treatment options for your chosen disorder discuss side effects, FDA approvals and warnings.  What is important to monitor in terms of labs, comorbid medical issues with why important for monitoring

6. Provide 3 examples of proper prescription that you would provide to the patient or transmit to the pharmacy.

Request for Solution File

Ask an Expert for Answer!!
Other Subject: Discuss fda and/or clinical practice guidelines
Reference No:- TGS03280353

Expected delivery within 24 Hours